APA (7e ed.) Bronvermelding

Choulwar Amol K. (2013). Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and safety of Antihyperparathyroidism and Antianginal D. NMIMS-SPPSPTM.

Chicago (17e ed.) Bronvermelding

Choulwar Amol K. Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and Safety of Antihyperparathyroidism and Antianginal D. Mumbai: NMIMS-SPPSPTM, 2013.

MLA (9e ed.) Bronvermelding

Choulwar Amol K. Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and Safety of Antihyperparathyroidism and Antianginal D. NMIMS-SPPSPTM, 2013.